Newsroom

Industry News

27 Jan

Onconova Therapeutics, Inc. to Present at NobleCON13

NEWTOWN, Pa., Jan. 27, 2017 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (ONTX), a Phase 3 clinical stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that Mark Guerin, Chief Financial Officer, will present a company overview at NobleCON13, Noble Capital Markets’ 13th annual...

Read more

25 Jan

MTBC Announces New Products and Important Events for 2017

SOMERSET, NJ–(Marketwired – Jan 25, 2017) – MTBC ( NASDAQ : MTBC ) ( NASDAQ : MTBCP ) today announces that it has lined up this year’s calendar with important healthcare tradeshows and conferences as part of its efforts to support new product launches in 2017 and ramp up...

Read more

24 Jan

Actinium’s Chief Medical Officer, Dr. Mark Berger, to Present Talk Titled, Iomab-B: Radiolabeled CD45 at the 3rd Annual Expert Forum on Acute Leukemias and Myeloproliferative Neoplasms

NEW YORK, Jan. 24, 2017 (GLOBE NEWSWIRE) — Actinium Pharmaceuticals, Inc. (ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that recently appointed Chief Medical Officer, Dr. Mark Berger, has been selected to present at the 3rd Annual...

Read more

24 Jan

Nephros Provides Corporate Update and Fourth Quarter 2016 Revenue Guidance

RIVER EDGE, NJ–(Marketwired – Jan 24, 2017) – Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of...

Read more

24 Jan

Aytu BioScience to Present at Noble Capital Markets’ 13th Annual Investor Conference

ENGLEWOOD, Colo., Jan. 24, 2017 /PRNewswire/ — Aytu BioScience, Inc. (AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that Josh Disbrow, Chairman & Chief Executive Officer, and Jarrett Disbrow, Chief Operating Officer, will present a corporate overview at NobleCon13...

Read more

23 Jan

PixarBio Corporation Terminates InVivo Therapeutics Bid

CAMBRIDGE, Mass.–(BUSINESS WIRE)— PixarBio Corporation, (PXRB) today announced that we will stay focused on our NeuroRelease Pain platform and continue to drive our non-opiate non addictive morphine replacement to market with FDA approval expected between the end of 2018 and early 2019. PixarBio has an IP portfolio covering pain,...

Read more

23 Jan

Ritter Pharmaceuticals Announces Collaboration with University of Nebraska to Explore Development of Microbiome Therapeutics in Metabolic Syndrome

LOS ANGELES, CA–(Marketwired – Jan 23, 2017) – Ritter Pharmaceuticals, Inc. ( NASDAQ : RTTR ) (“Ritter Pharmaceuticals” or the “Company”), a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today announced that it is collaborating with the newly-established Food for...

Read more

Page 30 of 239« First...1020...2829303132...405060...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address